Parkinson’s Foundation Announces Fall 2025 Moving Day Walks
Kizik and BlueRock Therapeutics to support events in 20 cities as National Partners
NEW YORK & MIAMI (September 16, 2025) —Today, the Parkinson’s Foundation announced the fall 2025 event lineup for Moving Day, a Walk for Parkinson’s. Moving Day is the Foundation’s signature fundraising event that unites supporters to take action in the fight against Parkinson’s (PD). With the support of this year’s National Partners, Kizik and BlueRock Therapeutics, Moving Day will take place in 20 cities across the country this fall.
“We are proud to announce our fall season sites and event dates – a testament to our commitment to reach PD communities throughout the United States,” said Kayln Henkel, executive vice president and chief development officer of the Parkinson’s Foundation. “Moving Day is a powerful reminder of what we can achieve together as teams and as individuals, collectively moving us closer to a cure.”
In addition to local events, the Foundation is also hosting Moving Day @ Home — a virtual walk experience that allows supporters to participate in Moving Day from anywhere in the country. The event welcomes walkers of all ages, speeds, and abilities, especially those without a nearby event.
"At Kizik, we believe in the power of movement – and that everyone is made to move," said Elizabeth Drori, Chief Marketing Officer at Kizik. "We're honored to partner with the Parkinson's Foundation—the nation's leading organization for those living with Parkinson's, their loved ones, and those working toward a cure —as a National Partner of Moving Day. Aligned with the Parkinson's Foundation's vision to make life better for people with Parkinson's, our hands-free shoes eliminate barriers and fuel independence. They're not just game-changing, they're life-changing."
"At BlueRock Therapeutics, we are driven to develop impactful new medicines that will help people living with Parkinson’s disease lead healthier lives," said Seth Ettenberg, Ph.D., President and CEO of BlueRock Therapeutics. "We have a shared commitment with the Parkinson’s Foundation to provide meaningful support to the Parkinson’s disease community and are proud to be a National Partner of Moving Day."
Since 2011, Moving Day has gathered more than 202,000 participants and raised more than $50.2 million to support the Foundation’s national mission of increasing access to quality care, advancing PD research toward a cure and providing free resources and local services for people living with PD and their families.
“Moving Day is much more than a fundraiser,” said John Poma, a member of the Foundation’s People with Parkinson’s Advisory Council and a Moving Day Indianapolis team captain. “Having a positive attitude is so important, and that is something the Parkinson’s Foundation offers. Through Moving Day, we can share the Foundation’s resources and help people live well with Parkinson’s.”
For more information on how to participate in a Moving Day event near you, visit MovingDayWalk.org or call the Parkinson’s Foundation free Helpline at 1-800-4PD-INFO (473-4636) for assistance in English or Spanish.
###
About the Parkinson’s Foundation
The Parkinson’s Foundation makes life better for people with Parkinson’s disease by improving care and advancing research toward a cure. In everything we do, we build on the energy, experience and passion of our global Parkinson’s community. Since 1957, the Parkinson’s Foundation has invested more than $474 million in Parkinson’s research and clinical care. Connect with us on Parkinson.org, Facebook, X, Instagram or call 1-800-4PD-INFO (1-800-473-4636).
About Parkinson’s Disease
Affecting an estimated one million Americans, Parkinson’s disease is the second-most common neurodegenerative disease after Alzheimer’s and is the 14th-leading cause of death in the U.S. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression), as well as non-motor symptoms (e.g., depression and anxiety). There is no cure for Parkinson’s and nearly 90,000 new cases are diagnosed each year in the U.S.
About Kizik
Based in Lindon, Utah, Kizik is the industry's leading hands-free footwear brand, recognized for its groundbreaking innovations and stylish designs. Kizik holds more than 200 pending and granted patents, offering a frictionless and convenient footwear experience for men, women, and kids. To learn more, visit kizik.com or follow @kizik.
About BlueRock Therapeutics LP
BlueRock Therapeutics LP is a clinical stage cell therapy company focused on creating cellular medicines to treat devastating diseases. We are harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. Bemdaneprocel has RMAT (Regenerative Medicine Advanced Therapy) and Fast Track designation from the US FDA (Food and Drug Administration) and is being tested in a Phase 3 clinical trial, exPDite-2. OpCT-001 has Fast Track designation from the FDA and is being tested in a Phase 1 clinical trial, Clarico. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer, the impact investing arm of Bayer AG that invests in paradigm-shifting breakthrough innovation. In late 2019, BlueRock became a wholly owned, independently operated subsidiary of Bayer AG. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves. For more information, visit www.bluerocktx.com.